Trial intelligence / Profile preview

Desflurane vs Propofol for GI Motility in Sleeve Gastrectomy

NCT05951686Completed

Sponsor
Bozyaka Training and Research Hospital
Start
Aug 2022
Primary completion
Oct 2023
Modality
Allosteric Modulators
Countries
1
01

Overview

Randomised, single-blind trial of desflurane and propofol injection (veterinary) in obesity (2 arms), sponsored by Bozyaka Training and Research Hospital. Primary endpoint: Gastrointestinal motility (peristalsis count). Started Aug 2022; status: completed.

02

Drugs

desfluranepropofol injection (veterinary)
03

Conditions

obesity

Beyond the preview

Go deeper on NCT05951686.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05951686.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call